Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Donor Specific Antibodies”

71 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 71 results

Not applicableStudy completedNCT03798860
What this trial is testing

Monitoring of Donor-specific Antibodies After Treatment With Immunoglobulins, Plasmapheresis and Rituximab in Lung Transplantation

Who this might be right for
Lung TransplantationDonor-specific Anti-human Leukocyte Antigen(HLA) Antibodies
Hannover Medical School 340
Post-approval studies (Phase 4)Study completedNCT03794492
What this trial is testing

Impact of Lymphocyte Anti-metabolite Immunosuppressions on Donor-Specific Anti-HLA Antibody and Kidney Graft Outcome

Who this might be right for
Kidney Transplant
Chong Kun Dang Pharmaceutical 169
Not applicableActive Not RecruitingNCT04277377
What this trial is testing

Nanoparticle for DSA Removal

Who this might be right for
Kidney FailurePresence of Donor Specific Antibodies
University of Zurich 100
Not applicableStudy completedNCT02633826
What this trial is testing

Pre-formed Alloreactivity in Renal Transplant Recipients

Who this might be right for
Kidney TransplantationAcute Graft Rejection
Martina Sester 190
Early research (Phase 1)Looking for participantsNCT06990711
What this trial is testing

Clinical Trial of Siltuximab for the Treatment of Antibody-Mediated Rejection After Lung Transplantation

Who this might be right for
Antibody Mediated Rejection of Lung Transplant
Washington University School of Medicine 30
Large-scale testing (Phase 3)Study completedNCT04302805
What this trial is testing

RATG Versus rATG Combined With Intravenous Immunoglobulin (IVIG) Induction Immunosuppression in HLA Incompatible Transplantation (INHIBIT)

Who this might be right for
Kidney Transplantation
Institute for Clinical and Experimental Medicine 17
Post-approval studies (Phase 4)Active Not RecruitingNCT04665310
What this trial is testing

Evaluation of Anti-rejection Drug, Tacrolimus, in African-Americans With Kidney Transplant

Who this might be right for
Kidney Disease, End-StageDonor Specific AntibodiesAcute Rejection of Renal Transplant
The Methodist Hospital Research Institute 46
Post-approval studies (Phase 4)Study completedNCT01044303
What this trial is testing

Reducing Donor Specific Antibody (DSA) Strength in Maintenance Kidney Transplant Recipients (DSA Study)

Who this might be right for
Transplant; Failure, Kidney
East Carolina University 32
Not applicableStudy completedNCT01545713
What this trial is testing

Correlation of Donor-specific Anti-endothelial Cells

Who this might be right for
Living-Donor Kidney Transplants
Northwestern University 16
Not applicableUnknownNCT02556879
What this trial is testing

Immunization Anti HLA in the Liver Transplant Recipients (DSATH)

Who this might be right for
Liver TransplantationGraft Failure
Assistance Publique - Hôpitaux de Paris 100
Not applicableStudy completedNCT05655208
What this trial is testing

Histological Profiles of Lung Allograft Transbronchial Biopsies and Clinical Outcomes After Lung Transplantation

Who this might be right for
Lung Transplant Rejection
Paris Translational Research Center for Organ Transplantation 498
Not applicableStudy completedNCT04026087
What this trial is testing

Subclass of Donor-specific Antibody as a Risk Factor of Antibody Mediated Rejection in Renal Transplantation

Who this might be right for
Antibody-mediated Rejection
University Hospital, Montpellier 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT03380962
What this trial is testing

Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant

Who this might be right for
Kidney Failure, ChronicEnd-Stage Renal DiseaseTransplant Glomerulopathy+4 more
Stanley Jordan, MD 20
Not applicableStudy completedNCT06395220
What this trial is testing

Kinectics of Donor-specific Anti-HLA Antibody After HLA-incompatible Allogeneic Haematopoietic Stem Cell Transplantation

Who this might be right for
Haematological Malignancy
Peking University People's Hospital 314
Not applicableStudy completedNCT07200583
What this trial is testing

Protein A Immunoadsorption in Highly Sensitized Haplo-HSCT Patients

Who this might be right for
Hematologic MalignanciesHematologic DisordersAllogeneic Hematopoietic Stem Cell Transplantation (HSCT)+1 more
Ting YANG 50
Testing effectiveness (Phase 2)Study completedNCT02426684
What this trial is testing

Ides in Highly Sensitized (HS) Patients Awaiting Kidney Transplantation

Who this might be right for
Renal Disease
Cedars-Sinai Medical Center 17
Not applicableUnknownNCT03815864
What this trial is testing

Antibodies and Liver Retransplantation

Who this might be right for
Liver Transplant FailureAntibody-mediated Rejection
London Health Sciences Centre 200
Not applicableActive Not RecruitingNCT02784080
What this trial is testing

Donor Specific HLA Alloantibodies in Liver Transplantation

Who this might be right for
Complication of Transplanted Liver
Rigshospitalet, Denmark 858
Testing effectiveness (Phase 2)Study completedNCT01178216
What this trial is testing

Use of Immune Globulin Plus Rituximab for Desensitization in Highly HLA Sensitized Patients Awaiting Deceased Donor Kidney Transplantation

Who this might be right for
End Stage Renal Disease
Stanley Jordan, MD 41
Post-approval studies (Phase 4)Study completedNCT04225988
What this trial is testing

Comparison of Tacrolimus Extended-Release (Envarsus XR) to Tacrolimus Immediate-Release in Human Leukocyte Antigen (HLA) Sensitized Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Rejection
Cedars-Sinai Medical Center 20
Next Page